NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
Back to search
Official data from USPTO
TAKEDA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/17/2024
Trademark type
Combined
Nice classes
10
Filing date
01/26/2024
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
12/17/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2020
First use in commerce
01/01/2020
Drawing code
3
Owner type
03
Owner location
Osaka, JP
Examiner
GRAJEDA, HECTOR
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "TAKEDA" in stylized lettering, appearing inside of two intersecting arcs, the lower arc with a straight line on the bottom and the higher arc being thicker in size and with two sides extending over the lower arc.
Holders and representatives
Holders
Takeda Pharmaceutical Company Limited
Representatives
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical devices used for administering pharmaceutical preparations for use in treating or diagnosingdisordersdiseasesrare diseases in the field of autoimmunologybacterial infection diseases and disorderscardiologycentral and peripheral nervous systems diseases and disordersdiabetesendocrinologyhematologyhormonal diseases and disordersgastroenterologygoutimmunologyinfectious diseases and disordersinflammatory diseases and disordersmusculoskeletal diseases and disordersneuroscienceoncologypain managementrespiratory diseases and disordersgenetic diseases and disordersurological diseases and disorderskidney diseases and disordersviral diseases and disorders; medical devices for reconstituting pharmaceutical preparations for use in treating or diagnosing disordersdiseasesrare diseases in the field of autoimmunologybacterial infection diseases and disorderscardiologycentral and peripheral nervous systems diseases and disordersdiabetesendocrinologyhematologyhormonal diseases and disordersgastroenterologygoutimmunologyinfectious diseases and disordersinflammatory diseases and disordersmusculoskeletal diseases and disordersneuroscienceoncologypain managementrespiratory diseases and disordersgenetic diseases and disordersurological diseases and disorderskidney diseases and disordersviral diseases and disorders; medical devices for reconstituting and administering pharmaceutical preparations. for use in treating or diagnosingdisordersdiseasesrare diseases in the field of autoimmunologybacterial infection diseases and disorderscardiologycentral and peripheral nervous systems diseases and disordersdiabetesendocrinologyhematologyhormonal diseases and disordersgastroenterologygoutimmunologyinfectious diseases and disordersinflammatory diseases and disordersmusculoskeletal diseases and disordersneuroscienceoncologypain managementrespiratory diseases and disordersgenetic diseases and disordersurological diseases and disorderskidney diseases and disordersviral diseases and disorders
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2024
GNRT
NON-FINAL ACTION E-MAILED
08/21/2024
CNRT
NON-FINAL ACTION WRITTEN
08/21/2024
DOCK
ASSIGNED TO EXAMINER
08/21/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/31/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2024
NWAP
NEW APPLICATION ENTERED
01/26/2024
Continuous trademark protection
Get notified about every new filing that threatens TAKEDA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.